INDOCONSEIndoco Remedies Limited· PharmaceuticalsMediumNeutral
Announced Thu, 25 Sept · 12:05 IST

Indoco Remedies Limited has informed the Exchange about Credit Rating

Rating Watch NegativeCredit & Debt View source PDF

INDOCO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

ICRA Limited has reaffirmed and assigned credit ratings for Indoco Remedies' various debt instruments as of 24th September 2025. Long-term instruments (term loans and cash credit totaling ~Rs 260.9 crore reaffirmed plus Rs 298.5 crore assigned) have been rated [ICRA]A with a Negative outlook. Short-term instruments (fund-based and non-fund-based limits totaling ~Rs 355.25 crore) have been rated [ICRA]A2+. The Negative outlook on long-term ratings signals potential credit pressure concerns noted by the rating agency.

Likely market impact

While the ratings themselves have been maintained, the Negative outlook on long-term debt is a caution flag for investors, suggesting ICRA sees risk of a future downgrade if the company's financial metrics don't improve. Existing shareholders should monitor for any deterioration in business performance or debt levels.